Drug Discovery & Research
OpenAI Loses Another AI Scientist to Booming Drug Discovery Gold Rush as Researcher Eyes $2 Billion Valuation
Miles Wang's departure to launch an AI-powered drug repurposing startup highlights the accelerating exodus of talent from general AI labs to specialized healthcare ventures.
Health AI Central Editorial Team·July 16, 2026